Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)Zhijie Wang, Lei Nie, Lin Wu et al.|Journal of Clinical Oncology|2022Cited by 177
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b StudyYuankai Shi, Tingting Song, Baolan Li et al.|Journal of Thoracic Oncology|2022Cited by 29
[A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer].Yan Huang, Li Zhang, Yunpeng Liu et al.|PubMed|2012Cited by 5
Efficacy and safety of ASK120067 (limertinib) in patients with locally advanced or metastatic EGFR T790M-mutated non–small cell lung cancer: A multicenter, single-arm, phase IIb study.Baolan Li, Yuankai Shi, Yu Zhang et al.|Journal of Clinical Oncology|2022Cited by 3
Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy.Caicun Zhou, Jielai Xia, Xia Song et al.|Journal of Clinical Oncology|2014Cited by 0